In rapidly growing human rhabdomyosarcoma (RD) cells, the IGF2 mRNA designated leader 4 (L4) is constitutively translated, whereas the IGF2 mRNA designated leader 3 (L3) is translated in a rapamycin-inhibitable manner, through an IRES-mediated mechanism. The gene discussed is IGF2; the disease is rhabdomyosarcoma.